COVID-19 therapeutic
/ NIPER, Hyderabad
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 30, 2021
Chitosan derivatives: A suggestive evaluation for novel inhibitor discovery against wild type and variants of SARS-CoV-2 virus.
(PubMed, Int J Biol Macromol)
- "Further ADMET analysis was done and found significant for exploration of the future therapeutic potential of these three ligands. The obtained results are highly encouraging in support for consideration and exploration in further clinical studies of these chitosan derivatives as anti-SARS-CoV-2 therapeutics."
Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1